Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Novel targeted therapies for Parkinson's disease.
Mol Med. 2021 Feb 25;27(1):17. doi: 10.1186/s10020-021-00279-2.
Mol Med. 2021.
PMID: 33632120
Free PMC article.
Review.
Euglycemia Indicates Favorable Motor Outcome in Parkinson's Disease.
Markaki I, Ntetsika T, Sorjonen K, Svenningsson P; BioPark Study Group.
Markaki I, et al. Among authors: ntetsika t.
Mov Disord. 2021 Jun;36(6):1430-1434. doi: 10.1002/mds.28545. Epub 2021 Feb 26.
Mov Disord. 2021.
PMID: 33634916
Item in Clipboard
Reply to: "HbA1c and Motor Outcome in Parkinson's Disease in the Mark-PD Study".
Markaki I, Ntetsika T, Svenningsson P.
Markaki I, et al. Among authors: ntetsika t.
Mov Disord. 2021 Aug;36(8):1993. doi: 10.1002/mds.28676.
Mov Disord. 2021.
PMID: 34409696
No abstract available.
Item in Clipboard
Isolation of L1CAM-Extracellular Vesicles Reveals Signs of Insulin Resistance in Parkinson's Disease.
Markaki I, Paslawski W, Ntetsika T, Engesvik L, Catrina SB, Svenningsson P.
Markaki I, et al. Among authors: ntetsika t.
Mov Disord. 2023 Nov;38(11):2136-2137. doi: 10.1002/mds.29601. Epub 2023 Sep 5.
Mov Disord. 2023.
PMID: 37670426
No abstract available.
Item in Clipboard
Cite
Cite